These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6262151)
1. Serially subcultivated cells as substrates for poliovirus production for vaccine. von Seefried A; Chun JH Dev Biol Stand; 1981; 47():25-33. PubMed ID: 6262151 [TBL] [Abstract][Full Text] [Related]
2. Monkey kidney cell growth optimization and poliovirus propagation in microcarrier culture. Mered B; Albrecht P; Hopps HE; Petricciani JC; Salk J Dev Biol Stand; 1981; 47():41-53. PubMed ID: 6262160 [TBL] [Abstract][Full Text] [Related]
3. Present state and developments in the production of inactivated poliomyelitis vaccine. van Wezel AL Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162 [TBL] [Abstract][Full Text] [Related]
4. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production. Larsson B; Litwin J Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000 [TBL] [Abstract][Full Text] [Related]
5. Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells. Mann GF; de Mucha J Dev Biol Stand; 1976 Dec 13-15; 37():255-8. PubMed ID: 201522 [TBL] [Abstract][Full Text] [Related]
6. The growth of polio virus in human diploid fibroblasts grown with cellulose microcarriers in suspension cultures. Larsson B; Litwin J Dev Biol Stand; 1987; 66():385-90. PubMed ID: 3034706 [TBL] [Abstract][Full Text] [Related]
7. The use of foetal, calf and adult bovine sera for the growth of serially subcultivated diploid cells. von Seefried A; MacMorine HG Dev Biol Stand; 1976 Dec 13-15; 37():83-9. PubMed ID: 1036405 [TBL] [Abstract][Full Text] [Related]
8. Growth limitations in high density microcarrier cultures. Butler M Dev Biol Stand; 1985; 60():269-80. PubMed ID: 3899789 [TBL] [Abstract][Full Text] [Related]
9. A perfusion culture system for virus vaccine manufacture in diploid cell cultures. Mann GF; de Mucha Macías J Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274 [TBL] [Abstract][Full Text] [Related]
10. Relative sensitivity of three cell substrates to the Sabin poliovirus strains. Kado G Dev Biol Stand; 1976 Dec 13-15; 37():261-4. PubMed ID: 201523 [TBL] [Abstract][Full Text] [Related]
11. Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells. Conceição MM; Tonso A; Freitas CB; Pereira CA Vaccine; 2007 Nov; 25(45):7785-95. PubMed ID: 17920165 [TBL] [Abstract][Full Text] [Related]
12. Production and control of live oral poliovirus vaccine in WI-38 human diploid cells. Stones PB Dev Biol Stand; 1976 Dec 13-15; 37():251-3. PubMed ID: 1036401 [TBL] [Abstract][Full Text] [Related]
13. Karyology and tumorigenicity testing requirements: past, present and future. Petricciani JC; Horaud FN Dev Biol Stand; 1998; 93():5-13. PubMed ID: 9737371 [TBL] [Abstract][Full Text] [Related]
14. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Genzel Y; Olmer RM; Schäfer B; Reichl U Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022 [TBL] [Abstract][Full Text] [Related]
15. Karyology: vaccine manufacturers' views. von Seefried A; Walton MJ; MacMorine HG Dev Biol Stand; 1976 Dec 13-15; 37():169-75. PubMed ID: 801470 [TBL] [Abstract][Full Text] [Related]
16. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys. van Wezel AL; van der Velden-de Groot CA; van Herwaarden JA Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995 [TBL] [Abstract][Full Text] [Related]
17. The development and use of microcarrier and glass sphere culture techniques for the production of herpes simplex viruses. Griffiths JB; Thornton B; McEntee I Dev Biol Stand; 1981; 50():103-10. PubMed ID: 6281104 [TBL] [Abstract][Full Text] [Related]
18. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale. Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818 [TBL] [Abstract][Full Text] [Related]
19. Production and glycosylation of recombinant beta-interferon in suspension and cytopore microcarrier cultures of CHO cells. Spearman M; Rodriguez J; Huzel N; Butler M Biotechnol Prog; 2005; 21(1):31-9. PubMed ID: 15903238 [TBL] [Abstract][Full Text] [Related]
20. Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells. Genzel Y; Ritter JB; König S; Alt R; Reichl U Biotechnol Prog; 2005; 21(1):58-69. PubMed ID: 15903241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]